<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three patients, a 28 years old female (case 1), and two males aged 32 and 18 (cases 2 and 3) received allogeneic bone marrow transplants for <z:hpo ids='HP_0011009'>acute</z:hpo> non lymphatic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (cases 1 and 2) and severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (case 3) from HLA identical siblings </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were conditioned with <z:chebi fb="0" ids="28901">Busulfan</z:chebi> and <z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi>, and received GVHD prophylaxis with cyclosporin and steroids </plain></SENT>
<SENT sid="2" pm="."><plain>Disease free survival is greater than 232, greater than 50 and greater than 201 days </plain></SENT>
<SENT sid="3" pm="."><plain>Hematological reconstitution was detected 12, 13 and 10 days post transplant </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients presented <z:hpo ids='HP_0001945'>fever</z:hpo> during the first month and received broad spectrum antibiotics including amphotericin in case 3 </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> GVHD presented in case 3 and <z:hpo ids='HP_0011010'>chronic</z:hpo> GVDH in case 1 </plain></SENT>
<SENT sid="6" pm="."><plain>Both patients responded to higher doses of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and steroids </plain></SENT>
<SENT sid="7" pm="."><plain>Allogeneic bone marrow transplant is a complex and expensive therapy, but can benefit a selected group of patients who fare poorly with conventional therapy </plain></SENT>
<SENT sid="8" pm="."><plain>This report communicates the first three successful allogeneic bone marrow transplants performed in Chile </plain></SENT>
</text></document>